Cabergoline

CAS 81409-90-7 8 current records 5 historicalSmall Molecule

Who holds supplier records for Cabergoline? 8 organisations hold a current record for Cabergoline: an active US FDA Type II Drug Master File or a CEP. A further 5 organisations have only historical (inactive) DMF filings. 6 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: India (2), Germany (1), Netherlands (1), Czech Republic (1) and 1 other country (1); not recorded for 2.

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records

Cite as: PharmaTek, “Cabergoline: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/cabergoline

Reading the evidence

  • 8 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • 1 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

Current records (8)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Cabergoline. Country is the organisation's recorded country, not necessarily the manufacturing site.

India2Germany1Netherlands1Czech Republic1Hungary1Country not recorded for 2
  • CF PHARMA LTD
    Active DMF 32145 · latest filing Oct 2017
  • FINETECH PHARMACEUTICAL LTD
    Active DMF 15423 · latest filing Apr 2001
    GermanyCEP
  • TAPI NL BV
    Active DMF 18113 · latest filing Feb 2005
    Netherlands
  • Apotex Pharmachem India Pvt. Ltd.
    Inactive DMF 26235, 22620 · latest filing Jul 2012
    IndiaCEP
  • TAPI Czech Industries s.r.o
    Czech RepublicCEP Company GMP cert on record
  • YS LIFE SCIENCE CO LTD
    CEP
  • CF PHARMA KFT.
    Valid CEP holder (EDQM); not necessarily the manufacturer
    HungaryCEP
  • LIFECARE LABORATORIES PRIVATE LIMITED
    Valid CEP holder (EDQM); not necessarily the manufacturer
    IndiaCEP
Need Cabergoline sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Valid CEP holder entries (6)

Certificates of Suitability on the EDQM register for Cabergoline, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 9 certificates in total, including withdrawn, expired, suspended and repeat certificates.

HolderCountryCertificateIssuedEU GMP at holder's address
CF PHARMA KFT. Budapest IXHU
CEP 2024-397 - Rev 00
Cabergoline
Oct 2026Inspected Jan 2026
Hungary
YS LIFE SCIENCE CO. LTD. Hwaseong-siKR
CEP 2024-349 - Rev 00
Cabergoline, Process II
Sept 2026—
TAPI CZECH INDUSTRIES S.R.O. OpavaCZ
CEP 2025-520 - Rev 00
Cabergoline, ID 702360
Jun 2026Inspected Oct 2024
Czechia
LIFECARE LABORATORIES PRIVATE LIMITED HyderabadIN
CEP 2023-093 - Rev 01
Cabergoline
Apr 2026—
APOTEX PHARMACHEM INDIA PVT. LTD BangaloreIN
CEP 2013-047 - Rev 03
Cabergoline
Jun 2024—
FINETECH PHARMACEUTICAL, LTD. NesherIL
R1-CEP 2008-235 - Rev 01
Cabergoline, Amorphous
Mar 2016—

The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.

Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.

Historical records (5)

Organisations whose Type II DMFs for Cabergoline are no longer active. These show a past filing, not current supply.

Show all 5 historical records
  • United States · Inactive DMF 28742 · filed Dec 2014
  • MYLAN LABORATORIES LTD
    Inactive DMF 23918 · filed Dec 2010
  • RESOLUTION CHEMICALS LTD
    Inactive DMF 18972 · filed Nov 2005
  • Hungary · Inactive DMF 18199 · filed Mar 2005
  • IVAX CR
    Inactive DMF 15933 · filed Mar 2002

Overview

Cabergoline is a long-acting dopamine receptor agonist used primarily in the treatment of disorders associated with hyperprolactinemia, including prolactin-secreting adenomas. It has been found effective in reducing prolactin levels and tumor size.

Chemical identity

IUPAC name
(6aR,9R,10aR)-N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)-7-prop-2-enyl-6,6a,8,9,10,10a-hexahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide
Canonical SMILES
CCNC(=O)N(CCCN(C)C)C(=O)[C@@H]1C[C@H]2[C@@H](CC3=CNC4=CC=CC2=C34)N(C1)CC=C
InChIKey
KORNTPPJEAJQIU-KJXAQDMKSA-N
Synonyms
Dostinex API, cabaser, dostinex, fce 21336, fce-21336, velactis

Pharmacologic class

As the US FDA states it for this active substance on product listings.

Established pharmacologic class
Ergot Derivative
Chemical structure
Ergolines

Therapeutic areas

EndocrinologyNeurologyGynecology

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Cabergoline?

8 organisations hold an active US FDA Type II Drug Master File or a CEP for Cabergoline: CF PHARMA LTD, FINETECH PHARMACEUTICAL LTD (Germany), TAPI NL BV (Netherlands), Apotex Pharmachem India Pvt. Ltd. (India), TAPI Czech Industries s.r.o (Czech Republic), YS LIFE SCIENCE CO LTD, CF PHARMA KFT. (Hungary) and LIFECARE LABORATORIES PRIVATE LIMITED (India). A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Cabergoline Drug Master Files are active?

CF PHARMA LTD (DMF 32145), FINETECH PHARMACEUTICAL LTD (DMF 15423) and TAPI NL BV (DMF 18113). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

What do the historical Cabergoline records mean?

5 organisations have only inactive Type II DMFs for Cabergoline. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.

Does Cabergoline have a European Certificate of Suitability?

Yes. 6 organisations hold a valid CEP for Cabergoline on the EDQM register, including CF PHARMA KFT. Budapest IX (HU), YS LIFE SCIENCE CO. LTD. Hwaseong-si (KR), TAPI CZECH INDUSTRIES S.R.O. Opava (CZ), LIFECARE LABORATORIES PRIVATE LIMITED Hyderabad (IN), APOTEX PHARMACHEM INDIA PVT. LTD Bangalore (IN) and FINETECH PHARMACEUTICAL, LTD. Nesher (IL). A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.

How do I qualify a Cabergoline supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Cabergoline?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.